A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) With or Without Intensity Modulated Radiation Therapy (IMRT) in the Treatment of Patients with Clinically Confined Prostate Adenocarcinoma

Disease (cancer type)

Prostate Cancer

Patient Selection Criteria

Patients with locally confined prostate adenocarcinoma (clinical stage T1c – T2bN0M0, Gleason score equal or less than 7, PSA equal or less than 20 ng/ml)

Research sponsor

21st Century Oncology

Reference ID#



  • Florida
To top